Vir Biotechnology's total assets for Q4 2025 were $1.00B, a decrease of -1.63% from the previous quarter. VIR total liabilities were $237.55M for the fiscal quarter, a 6.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.